24 results
Thumbnail

D1.259 - Healthcare interoperability: the promises and pitfalls relating to penicillin allergy delabelling

Thumbnail

D1.250 - Beyond the Label: A Multidisciplinary Effort to De-label Penicillin Allergy

Thumbnail

D1.251 - Documentation of drug allergy in the Electronic Health Record (EHR) at a Tertiary paediatric allergy service in the UK

Thumbnail

D1.252 - A model based economic evaluation to assess impact of Penicillin Allergy in COPD patients

Thumbnail

D1.253 - Comparison of Immune-Related Adverse Events in Patients Treated with Atezolizumab and Durvalumab: A Critical Concern for Clinical Management

Thumbnail

D1.254 - Assessing the Accuracy of Penicillin Allergy Labels in Paediatric Care: Focusing on Educational Gaps in Both Families and Healthcare Workers

Thumbnail

D1.255 - Validation of the English Version of the Drug Hypersensitivity Quality of Life Questionnaire (DrHy-Q): A Cross-Cultural Adaptation and Reliability Study

Thumbnail

D1.256 - Development of multiple drug hypersensitivity after DRESS syndrome induced by piperacillin/tazobactam

Thumbnail

D1.257 - Extensive allergological workup in the management of immediate adverse drug reactions to chemotherapy- a single centre experience

Thumbnail

D1.258 - Comparison of the Negative Predictive Values of One-Day and Five-Day Drug Provocation Tests in Late-Mild and Cutaneous Beta-Lactam Allergies in Children

Thumbnail

D1.260 - Hypersensitivity to Iodinated Contrast Media: Diagnostic Evaluation and Re-exposure Outcomes

Thumbnail

D1.248 - Perioperative hypersensitivity reaction (POH) with tranexamic acid: study of 2 cases

Thumbnail

D1.249 - Improving inpatient antimicrobial stewardship through single dose oral amoxicillin challenge among penicillin allergic veterans

Thumbnail

D1.90 - Remission of asthma on biological therapy: one center experience

Thumbnail

D1.98 - MV130 drives the differentiation of human monocytes into dendritic cells with antiallergic properties

Thumbnail

D1.102 - Md

Thumbnail

D1.88 - Mepolizumab and intestinal parasitic infection: A case report

Thumbnail

D1.91 - Baseline characteristics and main clinical outcomes of patients receiving tezepelumab in the framework of use in Special Situations prior to commercialization in Spain (T-ROSS Study)

Thumbnail

D1.92 - Results from the EGPAware Delphi study on Red Flags for Suspicion of Eosinophilic Granulomatosis with Polyangiitis (EGPA): current management in Europe

Thumbnail

D1.93 - ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up